0001855763-24-000006.txt : 20240510 0001855763-24-000006.hdr.sgml : 20240510 20240510165223 ACCESSION NUMBER: 0001855763-24-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240426 FILED AS OF DATE: 20240510 DATE AS OF CHANGE: 20240510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REESE ALBERT L JR CENTRAL INDEX KEY: 0001244736 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39874 FILM NUMBER: 24935758 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lexaria Bioscience Corp. CENTRAL INDEX KEY: 0001348362 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 202000871 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 BUSINESS ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 BUSINESS PHONE: 250-765-6424 MAIL ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 FORMER COMPANY: FORMER CONFORMED NAME: LEXARIA CORP. DATE OF NAME CHANGE: 20080229 FORMER COMPANY: FORMER CONFORMED NAME: Lexaria Corp. DATE OF NAME CHANGE: 20051229 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2024-04-26 0 0001348362 Lexaria Bioscience Corp. LEXX 0001244736 REESE ALBERT L JR 1 0 0 0 0 common shares 10917 D Stock Options 3 2021-02-01 2026-02-01 Common Shares 3400 3400 D Stock Options 3.39 2022-03-08 2027-03-08 Common Shares 3400 6800 D Stock Options 1.96 2022-10-12 2027-10-12 Common Shares 3200 10000 D Stock Options 0.87 2023-07-25 2028-07-25 Common Shares 5000 15000 D Stock Options 2.36 2024-04-26 4 A 0 5000 0 A 2024-04-26 2029-04-26 Common Shares 5000 20000 D Repriced from $4.80 pursuant to shareholder approval received on May 9, 2023 /Albert Reese Jr./ 2024-05-10